1. Clarke BL, Wynne AG, Wilson DM, Fitzpatrick LA. Osteomalacia associated with adult Fanconi's syndrome: clinical and diagnostic features. Clin Endocrinol (Oxf). 1995; 43(4):479–490.
Article
2. Izzedine H, Hulot JS, Launay-Vacher V, et al. Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: two double-blind, randomized, placebo-controlled studies. Kidney Int. 2004; 66(3):1153–1158.
Article
3. Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, et al. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years. Gastroenterology. 2006; 131(6):1743–1751.
4. Kim DH, Sung DH, Min YK. Hypophosphatemic osteomalacia induced by low-dose adefovir therapy: focus on manifestations in the skeletal system and literature review. J Bone Miner Metab. 2013; 31(2):240–246.
Article
5. Frame B, Parfitt AM. Osteomalacia: current concepts. Ann Intern Med. 1978; 89(6):966–982.
6. Eguchi H, Tsuruta M, Tani J, Kuwahara R, Hiromatsu Y. Hypophosphatemic osteomalacia due to drug-induced Fanconi's syndrome associated with adefovir dipivoxil treatment for hepatitis B. Intern Med. 2014; 53(3):233–237.
7. Law ST, Li KK, Ho YY. Nephrotoxicity, including acquired Fanconi's syndrome, caused by adefovir dipivoxil: is there a safe dose? J Clin Pharm Ther. 2012; 37(2):128–131.
8. Chamseddine AH, Alasiry AA, Zein HK. Spontaneous simultaneous bilateral femoral neck fractures secondary to osteomalacia: a case report and review of the literature. Eur J Orthop Surg Traumatol. 2012; 22:Suppl 1. 139–143.
Article
9. Tanaka M, Setoguchi T, Ishidou Y, et al. Pathological femoral fractures due to osteomalacia associated with adefovir dipivoxil treatment for hepatitis B: a case report. Diagn Pathol. 2012; 7:108.
Article
10. Della Rocca GJ. Gaps and opportunities in the management of the young femoral neck fracture. Injury. 2015; 46(3):515–518.
Article